• HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS)

    المصدر: Buzz FX / 08 أكتوبر 2024 15:22:11   America/Chicago


    HC Wainwright Reaffirms "Buy" Rating for Regulus Therapeutics (NASDAQ:RGLS) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" rating reissued
    Read more...
شارك على،